# OnCo record edigene (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/edigene/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "edigene" ;
  schema:name "EdiGene"@en ;
  schema:alternateName "博雅辑因"@en, "EdiGene (Beijing) Biotechnology"@en ;
  schema:description "EdiGene is a Beijing gene-editing company. It is developing donor-derived CAR-T cells for B-cell lymphoma and solid tumours, runs a screening system that edits genes at scale to find drug targets, and edits RNA inside the body for inherited diseases."@en ;
  schema:url <https://onco.cc/companies/edigene/>, <https://www.edigene.com/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.edigene.com/>, <https://www.edigene.com/company_overview/>, <https://www.edigene.com/our_pipeline/> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-cell-therapy/>, <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/crispr-screens/> .
